Literature DB >> 25872459

Sulfasalazine disposition in a subject with 376C>T (nonsense mutation) and 421C>A variants in the ABCG2 gene.

Keisuke Gotanda1, Tomoko Tokumoto1, Takeshi Hirota1, Masato Fukae1, Ichiro Ieiri1.   

Abstract

Entities:  

Keywords:  ABCG2; breast cancer resistance protein; genetic polymorphism; pharmacokinetics; sulfasalazine

Mesh：

Substances：

Year:  2015        PMID： 25872459      PMCID： PMC4631197          DOI： 10.1111/bcp.12654

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse.

Authors:  Hani Zaher; Anis A Khan; Joe Palandra; Timothy G Brayman; Linning Yu; Joseph A Ware
Journal:  Mol Pharm       Date:  2006 Jan-Feb       Impact factor: 4.939

2.  Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population.

Authors:  Hirotaka Matsuo; Tappei Takada; Kimiyoshi Ichida; Takahiro Nakamura; Akiyoshi Nakayama; Yuki Ikebuchi; Kousei Ito; Yasuyoshi Kusanagi; Toshinori Chiba; Shin Tadokoro; Yuzo Takada; Yuji Oikawa; Hiroki Inoue; Koji Suzuki; Rieko Okada; Junichiro Nishiyama; Hideharu Domoto; Satoru Watanabe; Masanori Fujita; Yuji Morimoto; Mariko Naito; Kazuko Nishio; Asahi Hishida; Kenji Wakai; Yatami Asai; Kazuki Niwa; Keiko Kamakura; Shigeaki Nonoyama; Yutaka Sakurai; Tatsuo Hosoya; Yoshikatsu Kanai; Hiroshi Suzuki; Nobuyuki Hamajima; Nariyoshi Shinomiya
Journal:  Sci Transl Med       Date:  2009-11-04       Impact factor: 17.956

3.  Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats.

Authors:  K M Das; J R Chowdhury; B Zapp; J W Fara
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682

Review 4.  Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2).

Authors:  Ichiro Ieiri
Journal:  Drug Metab Pharmacokinet       Date:  2011-11-29       Impact factor: 3.614

5.  Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport.

Authors:  Ai Tamura; Masato Watanabe; Hikaru Saito; Hiroshi Nakagawa; Toshiaki Kamachi; Ichiro Okura; Toshihisa Ishikawa
Journal:  Mol Pharmacol       Date:  2006-04-11       Impact factor: 4.436

6.  Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans.

Authors:  Y Yamasaki; I Ieiri; H Kusuhara; T Sasaki; M Kimura; H Tabuchi; Y Ando; S Irie; Ja Ware; Y Nakai; S Higuchi; Y Sugiyama
Journal:  Clin Pharmacol Ther       Date:  2008-01-02       Impact factor: 6.875

7.  Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta.

Authors:  Daisuke Kobayashi; Ichiro Ieiri; Takeshi Hirota; Hiroshi Takane; Shinji Maegawa; Junzo Kigawa; Hiroshi Suzuki; Eiji Nanba; Mitsuo Oshimura; Naoki Terakawa; Kenji Otsubo; Kazunori Mine; Yuichi Sugiyama
Journal:  Drug Metab Dispos       Date:  2004-10-08       Impact factor: 3.922
  7 in total
  1 in total

Review 1.  Medically Important Alterations in Transport Function and Trafficking of ABCG2.

Authors:  László Homolya
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.